Rebastinib
Product Specifications
CAS Number
1020172-07-9
Target
Apoptosis, FLT, Bcr-Abl, Src
Related Pathways
Apoptosis, Angiogenesis, Tyrosine Kinase/Adaptors, Cytoskeletal Signaling
Purity
0.9984
Bioactivity
DCC-2036 (Rebastinib (DCC-2036) ) is a conformational control Bcr-Abl inhibitor for Abl1 (WT, IC50: 0.8 nM) and Abl1 (T315I, IC50: 4 nM), also inhibits LYN, SRC, HCK, FGR, FLT3, KDR, and Tie-2, and low activity to c-Kit. Rebastinib aimed at the Angiopoietin2-Tie2 pathway.
Smiles
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc4ncccc4c3)C(C)(C)C)c(F)c2)ccn1
Molecular Formula
C30H28FN7O3
Molecular Weight
553.59
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
241818-01 100 mg
S-3- (1-Fmoc-pyrrolidin-2-yl) propionic acid 99+% (HPLC)
Sign In for Pricing
View Details 241818-02 250 mg
S-3- (1-Fmoc-pyrrolidin-2-yl) propionic acid 99+% (HPLC)
Sign In for Pricing
View Details 241818-03 1 g
S-3- (1-Fmoc-pyrrolidin-2-yl) propionic acid 99+% (HPLC)
Sign In for Pricing
View Details